Cargando…
Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review
RATIONALE: Small cell lung cancer (SCLC) is a lethal malignancy. Once relapsed, the disease is irreversible and most of the patients will die of cancer aggravation in 1 to 2 months. In the past several decades, little progress has been made in the systemic treatment of SCLC. Apatinib, as a novel sma...
Autores principales: | Zhao, Jun, Zhang, Xiaoling, Gong, Chaojie, Zhang, Jialei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815779/ https://www.ncbi.nlm.nih.gov/pubmed/29390367 http://dx.doi.org/10.1097/MD.0000000000009259 |
Ejemplares similares
-
S-1 plus apatinib followed by salvage esophagectomy for irinotecan-refractory small cell carcinoma of the esophagus: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020) -
Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: A case report and literature review
por: Zheng, Zhipeng, et al.
Publicado: (2017) -
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
por: Ding, Lin, et al.
Publicado: (2016) -
Apatinib plus retinoic acid as maintenance for children with relapsed stage 4 high-risk neuroblastoma: Two case reports
por: Jin, Mei, et al.
Publicado: (2020) -
Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017)